img

Global and India Drugs for Irritable Bowel Syndrome Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Drugs for Irritable Bowel Syndrome Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Drugs for Irritable Bowel Syndrome Market
This report focuses on global and India Drugs for Irritable Bowel Syndrome market, also covers the segmentation data of other regions in regional level and county level.
The global Drugs for Irritable Bowel Syndrome revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In India the Drugs for Irritable Bowel Syndrome revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Drugs for Irritable Bowel Syndrome include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG, AstraZeneca PLC, Ironwood Pharmaceuticals Inc. and Allergan Plc, Bausch Health Companies Inc., GlaxoSmithKline, Plc. and Lexicon Pharmaceuticals, Inc., etc. The global five biggest players hold a share of % in 2024.
Global Drugs for Irritable Bowel Syndrome Scope and Market Size
Drugs for Irritable Bowel Syndrome market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Drugs for Irritable Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Drugs for Irritable Bowel Syndrome market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Takeda Pharmaceutical Company Limited
Pfizer, Inc.
Abbott Laboratories
Novartis AG
AstraZeneca PLC
Ironwood Pharmaceuticals Inc. and Allergan Plc
Bausch Health Companies Inc.
GlaxoSmithKline, Plc.
Lexicon Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc.
Segment by Type
Alosetron
Lubiprostone
Linaclotide
Others

Segment by Application


Hospital
Clinic
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Drugs for Irritable Bowel Syndrome definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Drugs for Irritable Bowel Syndrome companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Drugs for Irritable Bowel Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Irritable Bowel Syndrome revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Drugs for Irritable Bowel Syndrome Product Introduction
1.2 Global Drugs for Irritable Bowel Syndrome Outlook 2018 VS 2024 VS 2034
1.2.1 Global Drugs for Irritable Bowel Syndrome Market Size for the Year 2018-2034
1.2.2 India Drugs for Irritable Bowel Syndrome Market Size for the Year 2018-2034
1.3 Drugs for Irritable Bowel Syndrome Market Size, India VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of India Drugs for Irritable Bowel Syndrome in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Drugs for Irritable Bowel Syndrome Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4 Drugs for Irritable Bowel Syndrome Market Dynamics
1.4.1 Drugs for Irritable Bowel Syndrome Industry Trends
1.4.2 Drugs for Irritable Bowel Syndrome Market Drivers
1.4.3 Drugs for Irritable Bowel Syndrome Market Challenges
1.4.4 Drugs for Irritable Bowel Syndrome Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Drugs for Irritable Bowel Syndrome by Type
2.1 Drugs for Irritable Bowel Syndrome Market Segment by Type
2.1.1 Alosetron
2.1.2 Lubiprostone
2.1.3 Linaclotide
2.1.4 Others
2.2 Global Drugs for Irritable Bowel Syndrome Market Size by Type (2018, 2024 & 2034)
2.3 Global Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2034)
2.4 India Drugs for Irritable Bowel Syndrome Market Size by Type (2018, 2024 & 2034)
2.5 India Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2034)
3 Drugs for Irritable Bowel Syndrome by Application
3.1 Drugs for Irritable Bowel Syndrome Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Drugs for Irritable Bowel Syndrome Market Size by Application (2018, 2024 & 2034)
3.3 Global Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2034)
3.4 India Drugs for Irritable Bowel Syndrome Market Size by Application (2018, 2024 & 2034)
3.5 India Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2034)
4 Global Drugs for Irritable Bowel Syndrome Competitor Landscape by Company
4.1 Global Drugs for Irritable Bowel Syndrome Market Size by Company
4.1.1 Global Key Companies of Drugs for Irritable Bowel Syndrome, Ranked by Revenue (2024)
4.1.2 Global Drugs for Irritable Bowel Syndrome Revenue by Player (2018-2023)
4.2 Global Drugs for Irritable Bowel Syndrome Concentration Ratio (CR)
4.2.1 Drugs for Irritable Bowel Syndrome Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Drugs for Irritable Bowel Syndrome in 2024
4.2.3 Global Drugs for Irritable Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Drugs for Irritable Bowel Syndrome Head office and Area Served
4.4 Global Key Players of Drugs for Irritable Bowel Syndrome, Product and Application
4.5 Global Key Players of Drugs for Irritable Bowel Syndrome, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Drugs for Irritable Bowel Syndrome Market Size by Company
4.7.1 Key Players of Drugs for Irritable Bowel Syndrome in India, Ranked by Revenue (2024)
4.7.2 India Drugs for Irritable Bowel Syndrome Revenue by Players (2021, 2024 & 2023)
5 Global Drugs for Irritable Bowel Syndrome Market Size by Region
5.1 Global Drugs for Irritable Bowel Syndrome Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Drugs for Irritable Bowel Syndrome Market Size by Region (2018-2034)
5.2.1 Global Drugs for Irritable Bowel Syndrome Market Size by Region: 2018-2023
5.2.2 Global Drugs for Irritable Bowel Syndrome Market Size by Region (2024-2034)
6 Americas
6.1 Americas Drugs for Irritable Bowel Syndrome Market Size YoY Growth 2018-2034
6.2 Americas Drugs for Irritable Bowel Syndrome Market Size by Type
6.2.1 Americas Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
6.2.2 Americas Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034)
6.2.3 Americas Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
6.3 Americas Drugs for Irritable Bowel Syndrome Market Size by Application
6.3.1 Americas Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
6.3.2 Americas Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034)
6.3.3 Americas Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
6.4 Americas Drugs for Irritable Bowel Syndrome Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Drugs for Irritable Bowel Syndrome Market Size YoY Growth 2018-2034
7.2 EMEA Drugs for Irritable Bowel Syndrome Market Size by Type
7.2.1 EMEA Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
7.2.2 EMEA Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034)
7.2.3 EMEA Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
7.3 EMEA Drugs for Irritable Bowel Syndrome Market Size by Application
7.3.1 EMEA Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
7.3.2 EMEA Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034)
7.3.3 EMEA Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
7.4 EMEA Drugs for Irritable Bowel Syndrome Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Drugs for Irritable Bowel Syndrome Market Size YoY Growth 2018-2034
8.2 China Drugs for Irritable Bowel Syndrome Market Size by Type
8.2.1 China Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
8.2.2 China Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034)
8.2.3 China Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
8.3 China Drugs for Irritable Bowel Syndrome Market Size by Application
8.3.1 China Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
8.3.2 China Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034)
8.3.3 China Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Drugs for Irritable Bowel Syndrome Market Size YoY Growth 2018-2034
9.2 APAC Drugs for Irritable Bowel Syndrome Market Size by Type
9.2.1 APAC Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
9.2.2 APAC Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034)
9.2.3 APAC Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
9.3 APAC Drugs for Irritable Bowel Syndrome Market Size by Application
9.3.1 APAC Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
9.3.2 APAC Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034)
9.3.3 APAC Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
9.4 APAC Drugs for Irritable Bowel Syndrome Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Takeda Pharmaceutical Company Limited
10.1.1 Takeda Pharmaceutical Company Limited Company Details
10.1.2 Takeda Pharmaceutical Company Limited Business Overview
10.1.3 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Introduction
10.1.4 Takeda Pharmaceutical Company Limited Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.1.5 Takeda Pharmaceutical Company Limited Recent Development
10.2 Pfizer, Inc.
10.2.1 Pfizer, Inc. Company Details
10.2.2 Pfizer, Inc. Business Overview
10.2.3 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Introduction
10.2.4 Pfizer, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.2.5 Pfizer, Inc. Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Details
10.3.2 Abbott Laboratories Business Overview
10.3.3 Abbott Laboratories Drugs for Irritable Bowel Syndrome Introduction
10.3.4 Abbott Laboratories Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.3.5 Abbott Laboratories Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Details
10.4.2 Novartis AG Business Overview
10.4.3 Novartis AG Drugs for Irritable Bowel Syndrome Introduction
10.4.4 Novartis AG Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.4.5 Novartis AG Recent Development
10.5 AstraZeneca PLC
10.5.1 AstraZeneca PLC Company Details
10.5.2 AstraZeneca PLC Business Overview
10.5.3 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Introduction
10.5.4 AstraZeneca PLC Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.5.5 AstraZeneca PLC Recent Development
10.6 Ironwood Pharmaceuticals Inc. and Allergan Plc
10.6.1 Ironwood Pharmaceuticals Inc. and Allergan Plc Company Details
10.6.2 Ironwood Pharmaceuticals Inc. and Allergan Plc Business Overview
10.6.3 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Introduction
10.6.4 Ironwood Pharmaceuticals Inc. and Allergan Plc Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.6.5 Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Development
10.7 Bausch Health Companies Inc.
10.7.1 Bausch Health Companies Inc. Company Details
10.7.2 Bausch Health Companies Inc. Business Overview
10.7.3 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Introduction
10.7.4 Bausch Health Companies Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.7.5 Bausch Health Companies Inc. Recent Development
10.8 GlaxoSmithKline, Plc.
10.8.1 GlaxoSmithKline, Plc. Company Details
10.8.2 GlaxoSmithKline, Plc. Business Overview
10.8.3 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Introduction
10.8.4 GlaxoSmithKline, Plc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.8.5 GlaxoSmithKline, Plc. Recent Development
10.9 Lexicon Pharmaceuticals, Inc.
10.9.1 Lexicon Pharmaceuticals, Inc. Company Details
10.9.2 Lexicon Pharmaceuticals, Inc. Business Overview
10.9.3 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Introduction
10.9.4 Lexicon Pharmaceuticals, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.9.5 Lexicon Pharmaceuticals, Inc. Recent Development
10.10 Sucampo Pharmaceuticals, Inc.
10.10.1 Sucampo Pharmaceuticals, Inc. Company Details
10.10.2 Sucampo Pharmaceuticals, Inc. Business Overview
10.10.3 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Introduction
10.10.4 Sucampo Pharmaceuticals, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023)
10.10.5 Sucampo Pharmaceuticals, Inc. Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Drugs for Irritable Bowel Syndrome Market Size India VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Drugs for Irritable Bowel Syndrome Market Trends
Table 3. Drugs for Irritable Bowel Syndrome Market Drivers
Table 4. Drugs for Irritable Bowel Syndrome Market Challenges
Table 5. Drugs for Irritable Bowel Syndrome Market Restraints
Table 6. Global Drugs for Irritable Bowel Syndrome Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Drugs for Irritable Bowel Syndrome Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Drugs for Irritable Bowel Syndrome Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Drugs for Irritable Bowel Syndrome Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Drugs for Irritable Bowel Syndrome, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Drugs for Irritable Bowel Syndrome Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Drugs for Irritable Bowel Syndrome Revenue Share by Player, 2018-2023
Table 13. Global Drugs for Irritable Bowel Syndrome Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs for Irritable Bowel Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Irritable Bowel Syndrome as of 2024)
Table 15. Global Key Players of Drugs for Irritable Bowel Syndrome, Headquarters and Area Served
Table 16. Global Key Players of Drugs for Irritable Bowel Syndrome, Product and Application
Table 17. Global Key Players of Drugs for Irritable Bowel Syndrome, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Drugs for Irritable Bowel Syndrome in India, Ranked by Revenue (2024) & (US$ Million)
Table 20. India Drugs for Irritable Bowel Syndrome Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. India Drugs for Irritable Bowel Syndrome Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Drugs for Irritable Bowel Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Drugs for Irritable Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Drugs for Irritable Bowel Syndrome Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Drugs for Irritable Bowel Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Drugs for Irritable Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Drugs for Irritable Bowel Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Drugs for Irritable Bowel Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Drugs for Irritable Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Drugs for Irritable Bowel Syndrome Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Drugs for Irritable Bowel Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Drugs for Irritable Bowel Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Drugs for Irritable Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Drugs for Irritable Bowel Syndrome Market Size by Region (2024-2034) & (US$ Million)
Table 51. Takeda Pharmaceutical Company Limited Company Details
Table 52. Takeda Pharmaceutical Company Limited Business Overview
Table 53. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product
Table 54. Takeda Pharmaceutical Company Limited Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 55. Takeda Pharmaceutical Company Limited Recent Development
Table 56. Pfizer, Inc. Company Details
Table 57. Pfizer, Inc. Business Overview
Table 58. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product
Table 59. Pfizer, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 60. Pfizer, Inc. Recent Development
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Drugs for Irritable Bowel Syndrome Product
Table 64. Abbott Laboratories Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Novartis AG Company Details
Table 67. Novartis AG Business Overview
Table 68. Novartis AG Drugs for Irritable Bowel Syndrome Product
Table 69. Novartis AG Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 70. Novartis AG Recent Development
Table 71. AstraZeneca PLC Company Details
Table 72. AstraZeneca PLC Business Overview
Table 73. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product
Table 74. AstraZeneca PLC Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 75. AstraZeneca PLC Recent Development
Table 76. Ironwood Pharmaceuticals Inc. and Allergan Plc Company Details
Table 77. Ironwood Pharmaceuticals Inc. and Allergan Plc Business Overview
Table 78. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product
Table 79. Ironwood Pharmaceuticals Inc. and Allergan Plc Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 80. Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Development
Table 81. Bausch Health Companies Inc. Company Details
Table 82. Bausch Health Companies Inc. Business Overview
Table 83. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product
Table 84. Bausch Health Companies Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 85. Bausch Health Companies Inc. Recent Development
Table 86. GlaxoSmithKline, Plc. Company Details
Table 87. GlaxoSmithKline, Plc. Business Overview
Table 88. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product
Table 89. GlaxoSmithKline, Plc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 90. GlaxoSmithKline, Plc. Recent Development
Table 91. Lexicon Pharmaceuticals, Inc. Company Details
Table 92. Lexicon Pharmaceuticals, Inc. Business Overview
Table 93. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product
Table 94. Lexicon Pharmaceuticals, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 95. Lexicon Pharmaceuticals, Inc. Recent Development
Table 96. Sucampo Pharmaceuticals, Inc. Company Details
Table 97. Sucampo Pharmaceuticals, Inc. Business Overview
Table 98. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product
Table 99. Sucampo Pharmaceuticals, Inc. Revenue in Drugs for Irritable Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 100. Sucampo Pharmaceuticals, Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Irritable Bowel Syndrome Product Picture
Figure 2. Global Drugs for Irritable Bowel Syndrome Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Drugs for Irritable Bowel Syndrome Market Size 2018-2034 (US$ Million)
Figure 4. India Drugs for Irritable Bowel Syndrome Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. India Drugs for Irritable Bowel Syndrome Market Size 2018-2034 (US$ Million)
Figure 6. India Drugs for Irritable Bowel Syndrome Market Share in Global 2018-2034
Figure 7. Drugs for Irritable Bowel Syndrome Report Years Considered
Figure 8. Product Picture of Alosetron
Figure 9. Product Picture of Lubiprostone
Figure 10. Product Picture of Linaclotide
Figure 11. Product Picture of Others
Figure 12. Global Drugs for Irritable Bowel Syndrome Market Share by Type in 2024 & 2034
Figure 13. Global Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2034) & (US$ Million)
Figure 14. Global Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 15. India Drugs for Irritable Bowel Syndrome Market Share by Type in 2024 & 2034
Figure 16. India Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2034) & (US$ Million)
Figure 17. India Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Drugs for Irritable Bowel Syndrome Market Share by Application in 2024 & 2034
Figure 22. Global Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2034) & (US$ Million)
Figure 23. Global Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 24. India Drugs for Irritable Bowel Syndrome Market Share by Application in 2024 & 2034
Figure 25. India Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2034) & (US$ Million)
Figure 26. India Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 27. The Top 5 and 10 Largest Companies of Drugs for Irritable Bowel Syndrome in the World: Market Share by Drugs for Irritable Bowel Syndrome Revenue in 2024
Figure 28. Global Drugs for Irritable Bowel Syndrome Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 29. Global Drugs for Irritable Bowel Syndrome Market Share by Region (2018-2034)
Figure 30. Americas Drugs for Irritable Bowel Syndrome Market Size Growth Rate 2018-2034 (US$ Million)
Figure 31. Americas Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 32. Americas Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 33. United States Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Canada Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Mexico Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Brazil Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. EMEA Drugs for Irritable Bowel Syndrome Market Size Growth Rate 2018-2034 (US$ Million)
Figure 38. EMEA Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 39. EMEA Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 40. Europe Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Middle East Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Africa Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. China Drugs for Irritable Bowel Syndrome Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. China Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 45. China Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 46. APAC Drugs for Irritable Bowel Syndrome Market Size Growth Rate 2018-2034 (US$ Million)
Figure 47. APAC Drugs for Irritable Bowel Syndrome Market Share by Type (2018-2034)
Figure 48. APAC Drugs for Irritable Bowel Syndrome Market Share by Application (2018-2034)
Figure 49. Japan Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. South Korea Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. China Taiwan Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. Southeast Asia Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. India Drugs for Irritable Bowel Syndrome Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 55. Pfizer, Inc. Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 56. Abbott Laboratories Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 58. AstraZeneca PLC Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 59. Ironwood Pharmaceuticals Inc. and Allergan Plc Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 60. Bausch Health Companies Inc. Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 61. GlaxoSmithKline, Plc. Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 62. Lexicon Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 63. Sucampo Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for Irritable Bowel Syndrome Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries